Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, 52-Week Trial of TTAX03 vs. Saline as a Single Intra-articular Injection in Kellgren-Lawrence Grade 3-4 Knee OA

NCT05079035 is registered in ClinicalTrials.gov with BioTissue Holdings, Inc as lead sponsor.

NCT NCT05079035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05079035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, 52-Week Trial of TTAX03 vs. Saline as a Single Intra-articular Injection in Kellgren-Lawrence Grade 3-4 Knee OA
Lead sponsor
BioTissue Holdings, Inc
Phase
Phase 2
Overall status
Completed
Start date
December 6, 2021
Completion date
March 7, 2025
Enrollment
90 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

knee arthritis, knee osteoarthritis, knee pain chronic